International Clinical Trial: Mechanism Study of Astragaloside IV in Improving Endometriosis Fibrosis via Mediating the PI3K/AKT Signaling Pathway

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132842) titled 'Mechanism Study of Astragaloside IV in Improving Endometriosis Fibrosis via Mediating the PI3K/AKT Signaling Pathway' on Sept. 18.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Yancheng First People's Hospital

Condition: Endometriosis (EM)

Intervention: Study group:None Control group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-01

Target Sample Size: Study group:100;Control group:100;Tissue collection group:20;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=335126

Published by...